Table 8 Gop-10 KEGG pathways, depicting functional enrichment in the network shown in Fig. 6J
#Term ID | Term description | Observed gene count | Background gene count | Strength | False discovery rate |
|---|---|---|---|---|---|
mmu05310 | Asthma | 2 | 24 | 2.49 | 0.0034 |
mmu05219 | Bladder cancer | 2 | 40 | 2.26 | 0.0048 |
mmu05330 | Allograft rejection | 2 | 50 | 2.17 | 0.0062 |
mmu05144 | Malaria | 2 | 53 | 2.14 | 0.0062 |
mmu04061 | Viral protein interaction with cytokine and cytokine receptor | 2 | 87 | 1.93 | 0.0136 |
mmu01522 | Endocrine resistance | 2 | 91 | 1.91 | 0.0136 |
mmu04657 | IL-17 signaling pathway | 2 | 90 | 1.91 | 0.0136 |
mmu05322 | Systemic lupus erythematosus | 2 | 93 | 1.9 | 0.0136 |
mmu05418 | Fluid shear stress and atherosclerosis | 3 | 141 | 1.89 | 0.0024 |
mmu04620 | Toll-like receptor signaling pathway | 2 | 98 | 1.88 | 0.0136 |